Fu Jie advertisement was accused of false propaganda and pharmaceutical industry clarified attempted

Because of recent media reports that "Fu Jie is a bottle of hand sanitizer," and questioned the Renhe pharmaceutical industry (000650.SZ) Fu Jie series of TV ads exist false propaganda. Renhe Pharmaceutical Industry Yesterday (March 28) suspended and issued a clarification announcement at night, said the company's products "Fu Jie" has bactericidal bacteriostasis, and product advertising in strict accordance with the relevant government departments for the release of the contents of the approval, there is no exaggerated false propaganda. It is understood that March 27 media reports said, in the Fu Jie products Production Enterprise Health license number, wrote "Gan Wei (2010) No. No. 0003" words. And according to the national "disinfection management measures" provisions, "Wei-Xiao Certificate" batch number for disinfection products, mainly used to kill or eliminate the media on the pathogen, is the Ministry of Health to improve the quality of public health approval of a class of products, daily commonly used hand sanitizer, wet paper towels, sanitary cotton, diapers and so on are "Wei-xiao" products. The article concluded that "Fu Jie is a bottle of disinfectant". Renhe pharmaceutical Industry Bulletin said, the current company in the market circulation "Fu Jie" brand series of products have three approval number, has a number of dosage forms and specifications, including "Fu Phlogistic Jie" brand Jie Yin Kang lotion and "Fu Jie" brand metronidazole chlorhexidine Lotion approved the number of 国药准字 Z20103066, the 国药准字 H20043498, and "Fu phlogistic Jie" brand herbal medicine Antibacterial Lotion standard number is q/jkm002, health permit for Gan Wei, the word (2010) Number No. 0003, health products are similar health supplies. Industry analysts believe that Renhe pharmaceutical industry in the announcement of the "Fu Jie" series of finished products in the "Fu Jie" brand herbal medicine bacteriostatic Lotion for health products, so Ren pharmaceutical advertising is playing a ball. Because only to get the name of the medicine can be called drugs, font-less products can not be advertised according to drugs. In the Ministry of Health issued the 2009 7th Bulletin, said that disinfection products and drugs are strictly different, disinfection products are not drugs, not the role of treatment of diseases. and repeatedly in the TV ads appear in the "Fu Jie" brand products is "Fu Jie" licensing plant herbal medicine antibacterial lotion; Fu Phlogistic Jie "series of products sales data also indicate that" Fu Jie "brand herbal medicine Antibacterial Lotion far home" Fu Jie "other products, also that is, the consumer in the market common" fu Jie "product is" Fu Jie "brand herbal medicine Antibacterial lotion, this publicity has induced consumers to believe that products have therapeutic efficacy. Benevolence and Pharmacy started out as an OTC, successful introduction of Cardin, can be Rickettsia, Fu Jie, shiny, positive stomach capsules, fire capsules, such as many well-known domestic brands, "Fu Jie" is the product of benevolence and medicine, is the main treatment of gynecological inflammation of proprietary Chinese medicine, belongs to the use of lotion. Guo Hai Securities Research Report, gynecological inflammation Market scale in 2012 years more than 10 billion yuan, of which the retail terminal OTC accounted for up to 63%, the hospital market accounted for 37%;OTC market, the proportion of proprietary Chinese medicine to 54.43%. Renhe Medicine "Fu phlogisticJie "After 10 years of cultivation, market share ranked in the top two." From China Kang Information · CMH's drug retail terminal monitoring data show that gynecological drug use in the domestic drug retail market in the last three years ranked in the 10th place before and after the 2009-2012-year contribution to the annual sales of 7.5 billion or so. The largest proportion of gynecological drugs in retail pharmacies is OTC, which is above 65%. Elimination "Font size products accounted for about 6%. In the gynecological drugs in the OTC, anti-inflammatory antibacterial class occupies a dominant position. Data show that Renhe pharmaceutical advertising, light research and development. From 2009 to 2011, its advertising and agency fees amounted to 117.75%, 58.3% and 44.33% of the net profit of the year, while the cost of its technology development was 2.0173 million yuan, 4.6438 million yuan, 1.7353 million yuan, which accounted for 0.21% and 0.34% of the current operating income. , 0.08%, far less than the average level of investment in research and development of domestic pharmaceutical enterprises. Earlier this morning, the shares of the composite card opened a fall of 7%, at the beginning of a fall of more than 9%.